SC Filed 2019-09-17 Event — SEC 0001144204-19-044911 →

Redmile Group, LLC → FATE THERAPEUTICS INC FATE

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 6.64

9,857,461 shares short · +5.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $1.50M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-20	Redmile Group, LLC	director, 10%+ owner	J	8,977,624	—	—

Other 13D/G Filings on FATE THERAPEUTICS INC

Filed	Form	Filer	Stake	Shares
2021-01-12	SC	Redmile Group, LLC	—	—	view →

Other Filings by Redmile Group, LLC

Filed	Form	Issuer	Stake	Shares
2022-07-06	SC	MedAvail Holdings, Inc.	—	—	view →
2022-01-14	SC	MedAvail Holdings, Inc.	—	—	view →
2021-11-29	SC	MedAvail Holdings, Inc.	—	—	view →
2021-03-01	SC	Augmedix, Inc.	—	—	view →
2021-01-12	SC	FATE THERAPEUTICS INC FATE	—	—	view →
2020-12-15	SC	IGM Biosciences, Inc.	—	—	view →
2020-09-10	SC	IGM Biosciences, Inc.	—	—	view →
2019-10-24	SC	ALDER BIOPHARMACEUTICALS INC	—	—	view →
2019-09-17	SC	ALDER BIOPHARMACEUTICALS INC	—	—	view →
2019-03-06	SC	ALDER BIOPHARMACEUTICALS INC	—	—	view →
2018-04-26	SC	ALDER BIOPHARMACEUTICALS INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →